The NCRI Bladder & Renal Group has five subgroups that develop research in areas of strategic need.

The Bladder Cancer Local Treatment Subgroup, chaired by Mr Param Mariappan, develops research into treatments for bladder cancer that hasn’t spread to other locations in the body.

Members:

Param Mariappan, Western General Hospital (subgroup chair)

Sally Appleyard, Sussex Cancer Centre

Simon Baker, Senior Post Doctoral Research Fellow, University of York

Alison Birtle, Consultant Clinical Oncologist and Honorary Clinical Senior Lecturer, Lancashire Teaching Hospitals NHS Foundation Trust

Rik Bryan, Senior Research Fellow, University of Birmingham

James Catto, Professor & Clinical Scientist, University of Sheffield

Alexandra Colquhoun, Addenbrooke’s Hospital NHS Foundation Trust

Emma Hall, Deputy Director, Institute of Cancer Research (ICR)

Ann Henry, Associate Professor in Clinical Oncology, Leeds Teaching Hospitals NHS Trust

Robert Huddart, Consultant Clinical Oncologist, Institute of Cancer Research (ICR)

Arabella Hunt, Clinical Research Fellow, Institute of Cancer Research (ICR)

Mark Johnson, Newcastle upon Tyne Hospitals NHS Foundation Trust

Ashok Nikapota, Consultant Clinical Oncologist, Sussex Cancer Centre

Yvonne Rimmer, Addenbrooke’s Hospital NHS Foundation Trust

Henry Scowcroft, Communications Strategy Lead, Cancer Research UK (CRUK)

Ashwin Sridhar, Consultant Urologist, University College London Hospitals NHS Foundation Trust (UCLH)

Anne Warren, Consultant Histopathologist, Cambridge University Hospitals NHS Foundation Trust

The Bladder Cancer Systemic Treatment Subgroup, chaired by Professor Syed Hussain, develops research into treatments for bladder cancer that work throughout the whole body.

Members:

Syed Hussain, Consultant in Medical Oncology, University of Sheffield (subgroup chair)

Alison Birtle, Consultant Clinical Oncologist and Honorary Clinical Senior Lecturer, Lancashire Teaching Hospitals NHS Foundation Trust

John Chester, Professor of Medical Oncology, Cardiff University

Ananya Choudhury, Chair and Honorary Consultant in Clinical Oncology, Christie NHS Foundation Trust

Maria de Santis, University of Warwick

Gareth Griffiths, University Hospital Southampton NHS Foundation Trust – Princess Anne Hospital

Robert Huddart, Consultant Clinical Oncologist, Institute of Cancer Research (ICR)

Robert Jones, Professor of Clinical Cancer Research and Honorary Consultant In Medical Oncology, University of Glasgow

Margaret Knowles, Professor of Experimental Cancer Research, University of Leeds

Thomas Powles, Clinical Professor of Genitourinary, Barts Health NHS Trust

Sundar Santhanam, King’s College London (KCL)

Naveed Sarwar, Trials Lead, Imperial College Healthcare NHS Trust – St Mary’s Hospital

Henry Scowcroft, Communications Strategy Lead, Cancer Research UK (CRUK)

The Penile Subgroup, chaired by Dr Vincent Khoo, develops research into cancer that occurs on the skin of the penis or within the penis.

Members:

Vincent Khoo, Consultant Clinical Oncologist, Royal Marsden NHS Foundation Trust (subgroup chair)

Amit Bahl, Honorary Senior Lecturer, University Hospitals Bristol NHS Foundation Trust

Jim Barber, Consultant Clinical Oncologist, Velindre NHS Trust

Dan Berney, Barts Health NHS Trust

Stephanie Burnett, Institute of Cancer Research (ICR)

Mark Callaway, University Hospitals Bristol NHS Foundation Trust

David Dickerson, King’s College London (KCL)

Roland Donat, NHS Lothian

Tony Elliot, Christie NHS Foundation Trust

Emma Hall, Deputy Director, Institute of Cancer Research (ICR)

Aditya Manjunath, King’s College London (KCL)

Suks Minhas, King’s College London (KCL)

Anita Mitra, University College London Hospitals NHS Foundation Trust (UCLH)

Asaf Muneer, University College London Hospitals NHS Foundation Trust (UCLH)

Steve Nicholson, King’s College London (KCL)

Jon Oxley, North Bristol NHS Trust

Heather Payne, King’s College London (KCL)

Matthew Perry, St George’s University Hospitals NHS Trust

Vijay Sangar, King’s College London (KCL)

Duncan Summerton, University Hospitals of Leicester NHS Trust

Miles Walkden, King’s College London (KCL)

Neil Walker, King’s College London (KCL)

Nick Watkin, St George’s University Hospitals NHS Trust

Mr David Wilkinson

The Renal Cancer Local Treatment Subgroup, chaired by Mr Axel Bex, develops research into treatments for cancer of the kidney that hasn’t spread to other locations in the body.

Members:

Axel Bex, Consultant Clinical Lead Renal Cancer, Royal Free London NHS Foundation Trust (subgroup chair)

Ravi Barod, Surgeon, Royal Marsden NHS Foundation Trust

Christopher Blick, Consultant Urological Surgeon, University of Oxford

Stephen Bromage, King’s College London (KCL)

Alison Fielding, NCRI Consumer Forum Member, Kidney Cancer Support Network

Kate Fife, Consultant Clinical Oncologist, Addenbrooke’s Hospital NHS Foundation Trust

Vincent Khoo, Consultant Clinical Oncologist, Royal Marsden NHS Foundation Trust

Tobias Klatte, Surgeon, Addenbrooke’s Hospital NHS Foundation Trust

Alex Laird, Surgeon, University of Edinburgh

Pieter Le Roux, King’s College London (KCL)

Satish Maddineni, Surgeon, Salford Royal NHS Foundation Trust

Tom Mitchell, Addenbrooke’s Hospital NHS Foundation Trust

David Nicol, Consultant Urologist & Chief of Surgery, Royal Marsden NHS Foundation Trust

Grenville Oades, NHS Greater Glasgow and Clyde

Grenville Oades, NHS Greater Glasgow and Clyde

Nair Rajesh, Guy’s and St Thomas’ NHS Foundation Trust

Mark Sullivan, King’s College London (KCL)

Maxine Tran, Surgeon, Royal Marsden NHS Foundation Trust

Anne Warren, Consultant Histopathologist, Cambridge University Hospitals NHS Foundation Trust

Simon Williams, Surgeon, University Hospitals of Derby and Burton NHS Foundation Trust

Rose Woodward

The Renal Cancer Systemic Treatment Subgroup, chaired by Dr Tom Waddell, develops research into treatments for cancer of the kidney that has spread to other areas of the body.

Members:

Tom Waddell, Consultant in Medical Oncology, Christie NHS Foundation Trust (subgroup chair)

Janet Brown, University of Sheffield

Natalie Charnley

Richard Griffiths, Clatterbridge Cancer Centre NHS Foundation Trust

James Larkin, Medical Oncologist, Royal Marsden NHS Foundation Trust

Salena Mulhere

Paul Nathan, East and North Hertfordshire NHS Trust

Lisa Pickering, Consultant Medical Oncologist, St George’s University Hospitals NHS Trust

Manon Pillai, Medical Oncology Specialist Trainee, Christie NHS Foundation Trust

Thomas Powles, Clinical Professor of Genitourinary, Barts Health NHS Trust

Christy Ralph, King’s College London (KCL)

Anand Sharma, Imperial College Healthcare NHS Trust – St Mary’s Hospital

Grant Stewart, Clinical Senior Lecturer and Honorary Consultant in Urological Surgery, University of Edinburgh

Stefan Symeonides, King’s College London (KCL)

Bernadett Szabados, Urologist, Barts and The London School of Medicine and Dentistry

Samra Turajlic, Consultant Medical Oncologist, Royal Marsden NHS Foundation Trust

Balaji Venugopal, NHS Greater Glasgow and Clyde